Immune Thrombocytopenia (ITP) Market Size, Share & Industry Analysis, By Type (Acute Immune Thrombocytopenia, and Chronic Immune thrombocytopenia), By Treatment (Thrombopoietin Receptor Agonist, Immunoglobulins, Corticosteroids, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others) and Regional Forecast, 2019-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI101682

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2015-2026
Base Year	2018
Forecast Period	2019-2026
Historical Period	2015-2017
Unit	Value (USD Billion)
Segmentation	By Type Acute Immune Thrombocytopenia Chronic Immune Thrombocytopenia
	By Treatment Thrombopoietin Receptor Agonist Immunoglobulins Corticosteroids Others
	By Distribution Channel Hospital Pharmacy Retail Pharmacy Others
	By Region/Country North America (U.S. and Canada) Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe) Asia Pacific (Japan, China, India, South Korea, Australia, and Rest of Asia Pacific) Latin America Middle East and Africa